Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SIM0815
- Development stage
- Preclinical
- Lead developer
- Simcere Pharmaceutical Group
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics
- Administration
- Intravenous, Subcutaneous
01
Overview
SIM0815 is a preclinical-stage bispecific antibody developed by Nanjing Zaiming Pharmaceutical, a subsidiary of Simcere, for the treatment of Alzheimer's disease. The molecule is specifically engineered to overcome the blood-brain barrier (BBB), which typically limits the entry of large-molecule therapeutics into the central nervous system. SIM0815 utilizes a BBB-penetrating shuttle mechanism to enhance its brain exposure, where it targets amyloid-beta (Aβ) to promote its clearance or inhibit its aggregation. By improving brain penetration compared to conventional monoclonal antibodies, SIM0815 aims to achieve superior therapeutic efficacy in addressing the amyloid pathology associated with Alzheimer's disease.
- Other names
- BBB-penetrating Aβ bispecific antibody
02
Targets
Aβ (Amyloid-beta peptides and aggregates)
Beyond the preview
Go deeper on SIM0815.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SIM0815.